Rakovina Therapeutics is a Canadian biotechnology company focused on developing cancer therapies based on DNA-damage response technologies. Its research programs target novel treatments intended to improve outcomes in oncology.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!